The Turkish experience of COVID-19 infection in people with NMOSD and MOGAD: A milder course?
MULTIPLE SCLEROSIS AND RELATED DISORDERS, vol.58, 2022 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 58
- Publication Date: 2022
- Doi Number: 10.1016/j.msard.2021.103399
- Journal Name: MULTIPLE SCLEROSIS AND RELATED DISORDERS
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
- Keywords: Neuromyelitis optica spectrum disorders, Myelin oligodendrocyte glycoprotein antibody-associated disorders, Disease modifying treatment, Coronavirus, SARS-CoV-2
- Ondokuz Mayıs University Affiliated: Yes
Abstract
Background: COVID-19 is a multisystemic infection with variables consequences depending on individual and comorbid conditions. The course and outcomes of COVID-19 during neuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disorders (MOGAD) are not clearly known.